Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Linezolid a better bug buster than teicoplanin

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Linezolid a better bug buster than teicoplanin. Pharmacoecon. Outcomes News 497, 4 (2006). https://doi.org/10.2165/00151234-200604970-00010

    Download citation

    Keywords

    • Outcome News
    • Medical Cost
    • Linezolid
    • Initial Therapy
    • Teicoplanin